Urinary Exosomal MicroRNAs As Biomarkers for Obesity-Associated Chronic Kidney Disease

Overview

Journal J Clin Med

Specialty General Medicine

Date 2022 Sep 23

PMID 36142918

Authors

Angel Earle

Madison Bessonny

Josh Benito

Kun Huang

Hannah Parker

Emily Tyler

Brittany Crawford

Nabeeha Khan

Bridget Armstrong

Alexis Stamatikos

Sudha Garimella

Alyssa Clay-Gilmour

Affiliations

Soon will be listed here.

Abstract

The early detection of chronic kidney disease (CKD) is key to reducing the burden of disease and rising costs of care. This need has spurred interest in finding new biomarkers for CKD. Ideal bi-omarkers for CKD should be: easy to measure; stable; reliably detected, even when interfering substances are present; site-specific based on the type of injury (tubules vs. glomeruli); and its changes in concentration should correlate with disease risk or outcome. Currently, no single can-didate biomarker fulfills these criteria effectively, and the mechanisms underlying kidney fibrosis are not fully understood; however, there is growing evidence in support of microRNA-mediated pro-cesses. Specifically, urinary exosomal microRNAs may serve as biomarkers for kidney fibrosis. In-creasing incidences of obesity and the recognition of obesity-associated CKD have increased interest in the interplay of obesity and CKD. In this review, we provide: (1) an overview of the current scope of CKD biomarkers within obese individuals to elucidate the genetic pathways unique to obesi-ty-related CKD; (2) a review of microRNA expression in obese individuals with kidney fibrosis in the presence of comorbidities, such as diabetes mellitus and hypertension; (3) a review of thera-peutic processes, such as diet and exercise, that may influence miR-expression in obesity-associated CKD; (4) a review of the technical aspects of urinary exosome isolation; and (5) future areas of research.

Citing Articles

Avgoustou E, Tzivaki I, Diamantopoulou G, Zachariadou T, Avramidou D, Dalopoulos V Diagnostics (Basel). 2025; 15(2).

PMID: 39857056 PMC: 11763674. DOI: 10.3390/diagnostics15020169.

[ Granules alleviates renal fibrosis in mice by regulating exosomes, miR-330-3p, and CREBBP expression].

Dai R, Cao Z, Liu C, Ge Y, Cheng M, Wang W Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(8):1431-1440.

PMID: 39276038 PMC: 11378048. DOI: 10.12122/j.issn.1673-4254.2024.08.01.

The Kidney in Obesity: Current Evidence, Perspectives and Controversies.

Kounatidis D, Vallianou N, Stratigou T, Voukali M, Karampela I, Dalamaga M Curr Obes Rep. 2024; 13(4):680-702.

PMID: 39141201 DOI: 10.1007/s13679-024-00583-y.

Integrated miRNA-mRNA Analysis Reveals Critical miRNAs and Targets in Diet-Induced Obesity-Related Glomerulopathy.

Lopez-Martinez M, Armengol M, Pey I, Farre X, Rodriguez-Martinez P, Ferrer M Int J Mol Sci. 2024; 25(12).

PMID: 38928144 PMC: 11204096. DOI: 10.3390/ijms25126437.

Nascent shifts in renal cellular metabolism, structure, and function due to chronic empagliflozin in prediabetic mice.

Shepard B, Chau J, Kurtz R, Rosenberg A, Sarder P, Border S Am J Physiol Cell Physiol. 2024; 326(4):C1272-C1290.

PMID: 38602847 PMC: 11193535. DOI: 10.1152/ajpcell.00446.2023.

References

Wang G, Kwan B, Lai F, Chow K, Kam-Tao Li P, Szeto C . Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy. Dis Markers. 2011; 30(4):171-9. PMC: 3825242. DOI: 10.3233/DMA-2011-0766. View

Wang J, Gao Y, Zhang N, Zou D, Wang P, Zhu Z . miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy. Mol Cell Endocrinol. 2014; 392(1-2):163-72. DOI: 10.1016/j.mce.2014.05.018. View

Liu X, Hong Q, Wang Z, Yu Y, Zou X, Xu L . Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells. Exp Biol Med (Maywood). 2015; 241(3):265-72. PMC: 4935438. DOI: 10.1177/1535370215605586. View

Zhang X, Guo L, Chi M, Sun H, Chen X . Identification of active miRNA and transcription factor regulatory pathways in human obesity-related inflammation. BMC Bioinformatics. 2015; 16:76. PMC: 4355475. DOI: 10.1186/s12859-015-0512-5. View

Merchant M, Rood I, Deegens J, Klein J . Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery. Nat Rev Nephrol. 2017; 13(12):731-749. PMC: 5941934. DOI: 10.1038/nrneph.2017.148. View

Zununi Vahed S, Omidi Y, Ardalan M, Samadi N . Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients. Clin Biochem. 2016; 50(1-2):32-39. DOI: 10.1016/j.clinbiochem.2016.08.007. View

Crepin D, Benomar Y, Riffault L, Amine H, Gertler A, Taouis M . The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment. Mol Cell Endocrinol. 2014; 384(1-2):1-11. DOI: 10.1016/j.mce.2013.12.016. View

Herget-Rosenthal S, Bokenkamp A, Hofmann W . How to estimate GFR-serum creatinine, serum cystatin C or equations?. Clin Biochem. 2007; 40(3-4):153-61. DOI: 10.1016/j.clinbiochem.2006.10.014. View

Hall J, Henegar J, Dwyer T, Liu J, da Silva A, Kuo J . Is obesity a major cause of chronic kidney disease?. Adv Ren Replace Ther. 2004; 11(1):41-54. DOI: 10.1053/j.arrt.2003.10.007. View

10.

Konoshenko M, Lekchnov E, Vlassov A, Laktionov P . Isolation of Extracellular Vesicles: General Methodologies and Latest Trends. Biomed Res Int. 2018; 2018:8545347. PMC: 5831698. DOI: 10.1155/2018/8545347. View

11.

Vojtech L, Woo S, Hughes S, Levy C, Ballweber L, Sauteraud R . Exosomes in human semen carry a distinctive repertoire of small non-coding RNAs with potential regulatory functions. Nucleic Acids Res. 2014; 42(11):7290-304. PMC: 4066774. DOI: 10.1093/nar/gku347. View

12.

Huang Y, Liu Y, Li L, Su B, Yang L, Fan W . Involvement of inflammation-related miR-155 and miR-146a in diabetic nephropathy: implications for glomerular endothelial injury. BMC Nephrol. 2014; 15:142. PMC: 4236663. DOI: 10.1186/1471-2369-15-142. View

13.

Levey A, Becker C, Inker L . Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA. 2015; 313(8):837-46. PMC: 4410363. DOI: 10.1001/jama.2015.0602. View

14.

da Silva F, Iop R, Andrade A, Costa V, Gutierres Filho P, da Silva R . Effects of Physical Exercise on the Expression of MicroRNAs: A Systematic Review. J Strength Cond Res. 2019; 34(1):270-280. DOI: 10.1519/JSC.0000000000003103. View

15.

Gheinani A, Vogeli M, Baumgartner U, Vassella E, Draeger A, Burkhard F . Improved isolation strategies to increase the yield and purity of human urinary exosomes for biomarker discovery. Sci Rep. 2018; 8(1):3945. PMC: 5834546. DOI: 10.1038/s41598-018-22142-x. View

16.

Huang Z, Shi J, Gao Y, Cui C, Zhang S, Li J . HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res. 2018; 47(D1):D1013-D1017. PMC: 6323994. DOI: 10.1093/nar/gky1010. View

17.

Ding W, Mak R . Early markers of obesity-related renal injury in childhood. Pediatr Nephrol. 2014; 30(1):1-4. DOI: 10.1007/s00467-014-2976-3. View

18.

Sandilands E, Dhaun N, Dear J, Webb D . Measurement of renal function in patients with chronic kidney disease. Br J Clin Pharmacol. 2013; 76(4):504-15. PMC: 3791974. DOI: 10.1111/bcp.12198. View

19.

Chen C, Hogan M, Ward C . Purification of exosome-like vesicles from urine. Methods Enzymol. 2013; 524:225-41. PMC: 4028690. DOI: 10.1016/B978-0-12-397945-2.00013-5. View

20.

Ong S, Lee W, Huang M, Dey D, Kodo K, Sanchez-Freire V . Response to letter regarding article, "Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer". Circulation. 2015; 131(12):e385. DOI: 10.1161/CIRCULATIONAHA.114.014467. View